Ulipristal acetate

CAS No. 126784-99-4

Ulipristal acetate ( CDB2914 )

Catalog No. M11121 CAS No. 126784-99-4

Ulipristal acetate(CDB2914) is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 41 In Stock
10MG 55 In Stock
50MG 113 In Stock
100MG 178 In Stock
200MG 267 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ulipristal acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ulipristal acetate(CDB2914) is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma.
  • Description
    Ulipristal acetate(CDB2914) is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma.
  • Synonyms
    CDB2914
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    PR
  • Research Area
    Endocrinology
  • Indication
    ——

Chemical Information

  • CAS Number
    126784-99-4
  • Formula Weight
    475.62
  • Molecular Formula
    C30H37NO4
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CC([C@@]1(OC(C)=O)CC[C@@]2([H])[C@]3([H])CCC4=CC(CCC4=C3[C@@H](C5=CC=C(N(C)C)C=C5)C[C@]12C)=O)=O
  • Chemical Name
    (8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Pohl O, et al. Int J Clin Pharmacol Ther. 2013 Jan;51(1):26-33.
molnova catalog
related products
  • GDC-0810

    GDC-0810 (ARN-810, Brilanestrant) is a non-steroidal, orally bioavailable selective estrogen receptor degrader (SERD) with IC50 of 0.7 nM (ER-α degradation).

  • Pipendoxifene hydroc...

    Pipendoxifene hydrochloride is a selective modulator of estrogen receptor.

  • Nafoxidine

    Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.